Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

5.05
Delayed Data
As of 3:59pm ET
 +0.28 / +5.87%
Today’s Change
3.22
Today|||52-Week Range
7.67
+1.41%
Year-to-Date
No recent news for Corcept Therapeutics Inc.

Today’s Trading

Previous close4.77
Today’s open4.75
Day’s range4.72 - 5.10
Volume267,193
Average volume (3 months)235,799
Market cap$523.3M
Dividend yield--
Data as of 3:59pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+80.65%
Earnings growth (this year)+145.83%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+89.39%
P/E ratioNM
Price/Sales10.59
Price/Book28.27

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.35+1.90%
OMEROmeros Corp0.000.00%
CLVSClovis Oncology Inc+0.63+4.53%
AIMTAimmune Therapeutics...+0.17+1.31%
Data as of 3:59pm ET, 05/02/2016

Financials

Last reporting dateMay 2, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$50.3M
Annual profit (last year)-$6.4M
Net profit margin-12.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary, Chief Financial &
Accounting Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs